Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cardiovascular Disorders

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Left ventricular non-compaction cardiomyopathy with coronary artery anomaly complicated by ventricular tachycardia

BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201717:263

https://doi.org/10.1186/s12872-017-0699-7

Received: 22 August 2017

Accepted: 10 October 2017

Published: 16 October 2017

Abstract

Background

Non-compaction cardiomyopathy (NCCM) is characterized by prominent trabeculations, deep intertrabecular recesses, and a thick non-compacted endocardial myocardium. Prevalence in the general population remains unclear, but echocardiography series report 0.05%. During fetal development muscle fibers and trabeculae should compact into a solid myocardium and when this fails, NCCM occurs. The condition is genetic, even though acquired forms have been described. Worsening myocardial dysfunction may lead to heart failure and/or arrhythmias.

Case presentation

A 52-year-old man presented with heart failure. The diagnosis of NCCM was confirmed after echocardiography and cardiac magnetic resonance tomography. Interestingly, the angiogram revealed a coronary anomaly, in which the circumflex artery rose aberrantly from the right coronary artery. Due to left ventricular ejection fraction being less than 35% despite optimal pharmacological therapy, an implantable cardioverter defibrillator (ICD) was implanted and four years later a ventricular tachycardia was terminated by antitachycardia pacing.

Conclusion

We describe a case of NCCM with a concomitant coronary anomaly, in which systolic myocardial dysfunction developed. The ICD subsequently terminated a life-threatening ventricular arrhythmia, which supports risk stratification based on low ejection fraction and possibly coronary anomaly.

Keywords

Cardiac imagingCardiac magnetic resonanceCardiomyopathyCoronary artery anomalyEchocardiographyHeart failure, implantable cardioverter defibrillatorNon-compaction cardiomyopathySudden cardiac deathVentricular tachycardia

Background

Non-compaction cardiomyopathy (NCCM) was first described in 1984 as a clinical entity and is a heterogeneous cardiomyopathy that can occur at any age [1, 2]. Congenital NCCM is caused by a defect in compaction of muscle fibers during fetal development, resulting in a spongiform myocardium. It appears that NCCM can also be acquired, for example due to athlete’s heart [3]. In a large hospital cohort the prevalence was 0.05%, and there seems to be an increased awareness among clinicians about NCCM [4]. Echocardiographic diagnosis is based on four criteria (Jenni criteria): absence of other cardiac abnormalities, end-systolic ratio between non-compacted endocardial myocardium and compacted epicardial myocardium of >2, localization of hyper-trabeculation to the apex/mid-inferior/mid-lateral areas, and color doppler showing blood flow from the ventricle into deep intertrabecular recesses without communication with coronary vessels [5]. Some patients with NCCM are asymptomatic, others develop heart failure with reduced systolic ejection fracture (EF). NCCM may increase the risk of ventricular tachycardia, and the risk of thromboembolism, likely due to reduced blood flow in the intertrabecular recesses [6]. NCCM exhibits familial clustering, with point prevalence of phenotype being 30% in first-degree relatives [7]. Genes encoding sarcomeric and cytoskeletal proteins have been implicated in NCCM, as well as genes previously linked to such disorders as hypertrophic cardiomyopathy, mitochondrial diseases, Barth syndrome, and myotonic dystrophy [8].

Case presentation

A 52-year-old man presented with dyspnea, chest discomfort, and palpitations upon exertion. His parents had confirmed ischemic heart disease. ECG at rest showed sinus rhythm, premature ventricular complexes and poor R-wave progression in precordial leads V1 to V4. The first echocardiography revealed general hypokinesia, predominantly in the anterior wall, thin walls without dilatation, EF around 35%, and high and pointy E-waves, indicative of a restrictive pattern. He reached 200 W on cycle ergometer exercise testing, but with frequent premature ventricular complexes. Angiography (Figs. 1 and 2.) showed no signs of coronary artery disease. Surprisingly, a coronary anomaly was revealed, in that the circumflex coronary artery (LCX) originated from the right coronary artery (RCA). At this point, cardiac magnetic resonance (CMR) imaging did not provide any further diagnostic clues. The situation was complicated by atrial fibrillation that was electrically converted but recurred at two-year follow-up. Another echocardiogram (Figs. 3, 4 and 5) was performed that for the first time raised suspicion of NCCM with EF around 30%. There were hypokinesia and deep intramyocardial recesses in the left ventricular wall. The ratio of non-compacted to compacted myocardium was 2.4 measured in the apical long-axis view, mid-inferior, at end-systole.
Fig. 1

Coronary angiogram, left anterior oblique view with caudal angulation showing left coronary artery and left anterior descending artery, without any circumflex artery (missing LCX)

Fig. 2

Coronary angiogram, right anterior oblique view with cranial angulation showing right coronary artery giving rise to a thin aberrant circumflex artery (aLCX)

Fig. 3

Transthoracic echocardiogram, end-diastole, apical four-chamber view showing prominent trabeculations in the left ventricular wall

Fig. 4

Transthoracic echocardiogram, systole, apical long-axis view showing a thick non-compacted myocardium in the left ventricular wall

Fig. 5

Transthoracic echocardiogram, end-diastole, parasternal short axis view showing hypertrabeculation of the inferolateral left ventricular wall

The patient was referred to a tertiary center for evaluation including right ventricular catheterization and endomyocardial biopsy that did not suggest any alternative diagnoses. Repeated echocardiograms confirmed the diagnosis of NCCM. An implantable cardioverter defibrillator (ICD) with a single lead (QRS < 120 ms) was offered to the patient for primary prevention of sudden cardiac death (SCD). Four years later, antitachycardia pacing terminated a life-threatening monomorphic ventricular tachycardia of 200 beats per minute (Fig. 6.). The patient has been followed for another three years and is on beta-blocker, angiotensin receptor blocker, and eplerenone therapy. In that time, he has had no further arrhythmias requiring ICD therapy and is New York Heart Association (NYHA) functional class II. The CARE guidelines were followed in the writing of this report.
Fig. 6

Electrocardiogram of monomorphic ventricular tachycardia, 200 beats per minute (paper speed 50 mm/s)

Discussion and conclusions

Clinical presentations of NCCM are heterogeneous and 35% have no hypertrophy or dilation of the ventricle. NCCM in the absence of arrhythmia seem to have similar survival rates as the general population [6]. Patients with NCCM with arrhythmia, are believed to have worse prognosis than patients with similar arrhythmias alone. Other forms of NCCM include dilated, hypertrophic, and restrictive pattern. NCCM typically affects the left ventricle, but biventricular and isolated right ventricular manifestations do occur [6]. There is no specific therapy for NCCM, but if heart failure is present this should be treated according to guidelines [9]. In our patient, metoprolol, enalapril, and eplerenone were titrated. The classic triad of NCCM consists of thromboembolism together with arrhythmia and heart failure. Anticoagulation is advocated if NCCM is associated with either atrial fibrillation, severe heart failure, confirmed thrombus, or previous thromboembolism [10]. In our patient, anticoagulation with warfarin was initiated due to atrial fibrillation and heart failure.

The Jenni echocardiography criteria are widely used but they can be difficult to validate and there is a lack of consensus about them [5]. CMR can provide additional value with borderline cases or in patients in whom differential diagnoses like hypertrophic cardiomyopathy are difficult to rule out. An end-diastolic ratio between non-compacted and compacted layers of >2.3 is considered diagnostic [11]. Late gadolinium enhancement in trabeculae is indicative of fibrosis and correlates with clinical severity [12].

This case report describes concomitant NCCM and aberrant LCX arising from the RCA, which occurs in 0.37% of angiograms [13]. Other coronary anomalies have previously been described together with NCCM, a single coronary artery of anomalous origin [14], as well as an anomaly including four arteries arising from the RCA with an LCX arising directly from the aorta [15]. How common coronary anomalies are in patients with NCCM is unknown, because the rarity of both conditions makes this difficult to study. Given the common pathogenesis of abnormalities in embryogenesis, an overrepresentation is plausible. The presence of coronary anomalies provides a challenge in risk stratification for SCD. The anomaly present in this case, aberrant LCX from the RCA, is generally not linked to an increased risk of SCD. In cases where the aberrant LCX travels between the aorta and the pulmonary artery, increased SCD has been reported, likely caused by compression or angulation of the artery [13].

The efficacy of ICD treatment in preventing death from arrhythmia is well established [16]. The European Society of Cardiology guidelines regarding SCD state that NCCM without further risk factors is not an indication for ICD. It is suggested to use the same criteria for risk stratification in NCCM as in non-ischemic, dilated cardiomyopathy [17]. ICDs should be offered to survivors of ventricular arrhythmias regardless of the underlying cardiac etiology. ICD should be offered as primary prophylaxis to NCCM patients with EF ≤35% and NYHA functional class II-III despite at least three months of optimal pharmacological therapy, and an otherwise reasonable life expectancy. Despite the limitations of EF estimation in individual patients, it still provides the best discriminator for risk stratification in most cardiomyopathy types [17, 18]. We believe that the current approach of risk stratification is advisable until more specific data of NCCM are available. The ICD in our patient terminated a life-threatening arrhythmia. This should encourage careful risk stratification in NCCM based on generalized knowledge from other cardiomyopathies.

Abbreviations

CMR: 

Cardiac magnetic resonance

EF: 

Ejection fraction

ICD: 

Implantable cardioverter defibrillator

LCX: 

Circumflex coronary artery

NCCM: 

Non-compaction cardiomyopathy

NYHA: 

New York Heart Association

RCA: 

Right coronary artery

SCD: 

Sudden cardiac death

Declarations

Acknowledgements

Images of the coronary angiogram were provided by Lasse Hellsten, and echocardiography exams by Ann-Charlotte Larsson. Jo Ann LeQuang of LeQ Medical reviewed the manuscript for American English use.

Funding

There is no funding pertaining to the manuscript.

Availability of data and materials

All relevant data supporting the conclusions of this article is included within the article.

Authors’ contributions

GM: design, data collection, major writing AB: design, writing HT: patient management, critical revision PM: idea, design, writing, patient and project management. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Centre for Research and Development, Uppsala University/Region Gävleborg
(2)
Department of Medicine, Kiruna sjukhus
(3)
Cardiology Research Unit, Department of Medicine, Karolinska Institutet

References

  1. Engberding R, Bender F. Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: persistence of isolated myocardial sinusoids. Am J Cardiol. 1984;53:1733–4.View ArticlePubMedGoogle Scholar
  2. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.View ArticlePubMedGoogle Scholar
  3. Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99:401–8.View ArticlePubMedGoogle Scholar
  4. Ritter M, Oechslin E, Sütsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72:26–31.View ArticlePubMedGoogle Scholar
  5. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666–71.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015;386:813–25.View ArticlePubMedGoogle Scholar
  7. Bhatia NL, Tajik AJ, Wilansky S, Steidley DE, Mookadam F. Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. J Card Fail. 2011;17:771–8.View ArticlePubMedGoogle Scholar
  8. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol. 2009;30:659–81.View ArticlePubMedGoogle Scholar
  9. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.View ArticlePubMedGoogle Scholar
  10. Finsterer J, Stöllberger C, Towbin JA. Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors. Nature reviews. Cardiology. 2017;14:224–37.PubMedGoogle Scholar
  11. Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;5(46):101–5.View ArticleGoogle Scholar
  12. Dodd JD, Holmvang G, Hoffmann U, Ferencik M, Abbara S, Brady TJ, et al. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. Am J Roentgenol. 2007;189:974–80.View ArticleGoogle Scholar
  13. Villa AD, Sammut E, Nair A, Rajani R, Bonamini R, Chiribiri A. Coronary artery anomalies overview: the normal and the abnormal. World J Radiol. 2016;8:537–55.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Park JS, Shin DG, Kim YJ, Hong GR, Kim W, Lee SH, et al. Left ventricular noncompaction with a single coronary artery of anomalous origin. Int J Cardiol. 2007;119:35–7.View ArticleGoogle Scholar
  15. Iacovelli F, Pepe P, Contegiacomo G, Alberotanza V, Masi F, Bortone AS, et al. A striking coronary artery pattern in a grown-up congenital heart disease patient. Case Rep Cardiol. 2016;2016:5482578.PubMedPubMed CentralGoogle Scholar
  16. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the multicenter automatic defibrillator implantation trial II. Circulation. 2010;122:1265–71.View ArticlePubMedGoogle Scholar
  17. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793–867.View ArticlePubMedGoogle Scholar
  18. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement